Peginterferon

Exposed non-exposed, cohort studies

Study Country
Study period
Study design
Data source Exposure definition Non-exposure definition Exposition period Sample size
(exposed/unexposed) Or (case / control)
Remarks Overall risk of bias
Beauverd
2016
United Kingdom
2013 - 2015
retrospective cohort
Pregnancies in essential thrombocythemia (ET) women treated with Pegylated interferon alpha-2a (PEG-IFN). exposed to other treatment, sick
Previous pregnancies in the same women without use of Pegylated interferon alpha-2a (PEG-IFN).
during pregnancy (anytime or not specified) 10 / 9 Other treatments in control group: low dose aspirin, ow molecular weight heparin (LMWH), IFN. NA
Demographics, past medical and obstetric history, previous thrombosis and hemorrhage, previous treatment, disease characteristics at diagnosis and during pregnancy were retrospectively extracted from patients’ notes.

Case-control studies

Study Country
Study period
Study design
Data source Case Control Exposition Exposition period Sample size
(exposed/unexposed) Or (case / control)
Remarks Overall risk of bias

Empty. There are no case-control studies available for this drug.

See the method used to produce these results